- Tim Cook Should Tell Congress to Kiss His Ass
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- 5 Worst Home Renovation Projects
- How the New York Hedge Funds Lost Their Shirts on Tesla
- What You Wear to the Office Still Matters
Apple: Keep Tim Cook's Feet to the Fire
Don't associate Tim Cook's performance on Capitol Hill with his ability to innovate at Apple.
The hottest stocks, in particular, could see some real mayhem ahead.
The market's P/E ratio appears to be stretched.
Thanks to health-conscious millennials, this company is in fine shape.
Cramer wants you to wait on Corning and AT&T and he's watching Oracle.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
Don't associate Tim Cook's performance on Capitol Hill with his ability to innovate at Apple.
Cramer wants you to wait on Corning and AT&T and he's watching Oracle.
Investors can clean up with Clean Harbors, have fun with Six Flags and dine out on Whole Foods, Cramer said.
Will big companies really build clouds incompatible with those they can rent?
Wendy's is not completely out of the woods just yet. But the company seems to be heading on the right path.
It's mainly men letting rewards points come and go, expiring even as they travel once a week or more.
The health care REIT should do well when the federal health insurance law fully kicks in.
Rue21 has agreed to its second buyout by private equity firm Apax Partners.
Most women in a survey would give up sex before their smartphone -- which they'll use to break up with you.
Hotelier seen sitting on $7 in excess capital that could be returned to shareholders.
U.S. stocks stumble Thursday, even after better-than-expected labor and real estate reports.
CBOE's Russell Rhoads says there are two pieces of the puzzle that should help lead to the best option to buy or sell depending on your stock price forecast.
In the options market, hefty spreads on the XLF have been noteworthy and seem to be expressing concerns about a possible pullback in months ahead.
If you are unfamiliar with VIX derivatives, this is the week to watch the VIX options and futures move.
Two charts show how investors feel differently about Keryx and Acadia Pharma.
One trader believes Rockwell shares will rise into clinical trial results expected in July.
An updated list of the biotech and drug firms expecting FDA drug approval decisions in 2013.
Rue21 has agreed to its second buyout by private equity firm Apax Partners.
The New York Post has played pitbull as News Corp. attempts to chip away at Bloomberg's profitable analytics business.
Why taxpayers will only be able to view Tesla as a winning stimulus.
Jim Cramer believes Hewlett-Packard is back, but he's in wait and see mode before calling it an investment.
Investors may have been warming to HP ahead of its second-quarter results, but there are plenty of hurdles in CEO Meg Whitman's path.
HP's first-quarter earnings beat Wall Street expectations, sending the stock soaring in after-hours.
Children's Place spikes Thursday after the children's apparel retailer lifts its fiscal-year guidance despite disappointing earnings results.
General Electric CEO Jeff Immelt on Tuesday reiterated the firm's plan to keep shrinking its finance arm, hinting at possible spinoffs.
Hotelier seen sitting on $7 in excess capital that could be returned to shareholders.
Two charts show how investors feel differently about Keryx and Acadia Pharma.
Tesla says it's the only U.S. automaker to repay its federal loans, but Chrysler paid back its loans in 2011.
Don't associate Tim Cook's performance on Capitol Hill with his ability to innovate at Apple.
When all is said and done, it's all about the actual driving experience.
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
|
|
|
|
|
|
|
|
|
|
|
|